Clinical Trials Browser

Pancreatic Adenocarcinoma × Losartan × Gastrointestinal × Clear all

NCT05077800 2025-11-18

FOLFIRINOX + Elraglusib + Losartan In Pancreatic Cancer

Phase 2 Active not recruiting

Gastrointestinal

Pancreatic Adenocarcinoma